BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
Reprints
Employer-sponsored health plans pay significantly more than Medicare for costly physician-administered drugs, threatening access to lifesaving treatments, according to a newly published analysis of claims data and Medicare files, reports Axios. Price markups increased between 2016 and 2020 for five of the top 10 drugs that account for the most spending and more than doubled for three: the white blood cell-booster pegfilgrastim and the cancer drugs trastuzumab and rituximab, according to a report by the Health Care Cost Institute published in JAMA Health Forum.
1. TPA exec pleads guilty to embezzling client health care funds
2. Report warns of high costs if Medicare expanded to cover anti-obesity drugs
3. Top health insurance startups posted combined $2 billion in losses in 2022
5. Local governments opting out of Colorado paid leave program
6. Cerebral discloses sharing mental health patient info with social media giants